Skip to main content
Log in

Transaldolase deficiency caused by the homozygous p.R192C mutation of the TALDO1 gene in four Emirati patients with considerable phenotypic variability

  • Original Article
  • Published:
European Journal of Pediatrics Aims and scope Submit manuscript

Abstract

Transaldolase deficiency is a heterogeneous disorder of carbohydrate metabolism characterized clinically by dysmorphic features, cutis laxa, hepatosplenomegaly, hepatic fibrosis, pancytopenia, renal and cardiac abnormalities, and urinary excretion of polyols. This report describes four Emirati patients with transaldolase deficiency caused by the homozygous p.R192C missense mutation in TALDO1 displaying wide phenotypic variability. The patients had variable clinical presentations including hepatosplenomegaly, pancytopenia, liver failure, proteinuria, hydrops fetalis, cardiomyopathy, and skin manifestations (e.g., dryness, cutis laxa, ichthyosis, telangiectasias, and hemangiomas). Biochemical analyses including urinary concentration of polyols were consistent with transaldolase deficiency. The mutation p.R192C was previously identified in an Arab patient, suggesting a founder effect in Arab populations.

Conclusion: The above findings support the premise that biallelic mutations in TALDO1 are responsible for transaldolase deficiency and confirm the broad phenotypic variability of this condition, even with the same genotype.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

Abbreviations

ALP:

Alkaline phosphatase

ALT:

Alanine transaminase

ANC:

Absolute neutrophil count

APTT:

Activated partial thromboplastin time

ASD:

Atrial septal defect

AST:

Aspartate transaminase

ATP:

Adenosine triphosphate

BMI:

Body mass index

CBC:

Complete blood count

DNA:

Deoxyribonucleic acid

EDTA:

Ethylenediaminetetraacetic acid

GGT:

Gamma-glutamyl transpeptidase

GSH:

Glutathione

Hb:

Hemoglobin

INR:

International normalized ratio

IVC:

Inferior vena cava

MRI:

Magnetic resonance imaging

NADPH:

Nicotinamide adenine dinucleotide phosphate

NG:

Nasogastric

PCR:

Polymerase chain reaction

PDA:

Patent ductus arteriosus

PFO:

Patent foramen ovale

PPP:

Pentose phosphate pathway

PT:

Prothrombin time

RNA:

Ribonucleic acid

UAE:

United Arab Emirates

US:

Ultrasound

WBC:

White blood cell

References

  1. Adams MD, Kerlavage AR, Fleischmann RD, Fuldner RA, Bult CJ, Lee NH, White O (1995) Initial assessment of human gene diversity and expression patterns based upon 83 million nucleotides of cDNA sequence. Nature 377(6547 Suppl):3–174

    CAS  PubMed  Google Scholar 

  2. Balasubramaniam S, Wamelink MM, Ngu LH, Talib A, Salomons GS, Jakobs C, Keng WT (2011) Novel heterozygous mutations in TALDO1 gene causing transaldolase deficiency and early infantile liver failure. J Pediatr Gastroenterol Nutr 52(1):113–116. doi:10.1097/MPG.0b013e3181f50388

    Article  CAS  PubMed  Google Scholar 

  3. Banki K, Halladay D, Perl A (1994) Cloning and expression of the human gene for transaldolase. A novel highly repetitive element constitutes an integral part of the coding sequence. J Biol Chem 269(4):2847–2851

    CAS  PubMed  Google Scholar 

  4. Crooks GE, Hon G, Chandonia JM, Brenner SE (2004) WebLogo: a sequence logo generator. Genome Res 14(6):1188–1190. doi:10.1101/gr.849004

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  5. Cutting GR (2010) Modifier genes in Mendelian disorders: the example of cystic fibrosis. Ann N Y Acad Sci 1214:57–69. doi:10.1111/j.1749-6632.2010.05879.x

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  6. Eyaid W, Al Harbi T, Anazi S, Wamelink MM, Jakobs C, Al Salammah M, Alkuraya FS (2013) Transaldolase deficiency: report of 12 new cases and further delineation of the phenotype. J Inherit Metab Dis 36(6):997–1004. doi:10.1007/s10545-012-9577-8

    Article  CAS  PubMed  Google Scholar 

  7. Friedman T, Battey J, Kachar B, Riazuddin S, Noben-Trauth K, Griffith A, Wilcox E (2000) Modifier genes of hereditary hearing loss. Curr Opin Neurobiol 10(4):487–493

    Article  CAS  PubMed  Google Scholar 

  8. Hanczko R, Fernandez DR, Doherty E, Qian Y, Vas G, Niland B, Perl A (2009) Prevention of hepatocarcinogenesis and increased susceptibility to acetaminophen-induced liver failure in transaldolase-deficient mice by N-acetylcysteine. J Clin Invest 119(6):1546–1557. doi:10.1172/JCI35722

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  9. Heinrich PC, Morris HP, Weber G (1976) Behavior of transaldolase (EC 2.2.1.2) and transketolase (EC 2.2.1.1) activities in normal, neoplastic, differentiating, and regenerating liver. Cancer Res 36(9pt.1):3189–3197

    CAS  PubMed  Google Scholar 

  10. Huck JH, Struys EA, Verhoeven NM, Jakobs C, van der Knaap MS (2003) Profiling of pentose phosphate pathway intermediates in blood spots by tandem mass spectrometry: application to transaldolase deficiency. Clin Chem 49(8):1375–1380

    Article  CAS  PubMed  Google Scholar 

  11. Jassim N, Alghaihab M, Saleh SA, Alfadhel M, Wamelink MM, Eyaid W (2014) Pulmonary manifestations in a patient with transaldolase deficiency. JIMD Rep 12:47–50. doi:10.1007/8904_2013_243

    Article  PubMed Central  PubMed  Google Scholar 

  12. LeDuc CA, Crouch EE, Wilson A, Lefkowitch J, Wamelink MMC, Jakobs C, Salomons GS, Sun X, Shen Y, Chung WK (2013) Novel association of early onset hepatocellular carcinoma with transaldolase deficiency. JIMD Rep. doi:10.1007/8904_2013_254

    PubMed Central  PubMed  Google Scholar 

  13. Loeffen YG, Biebuyck N, Wamelink MM, Jakobs C, Mulder MF, Tylki-Szymańska A, Bökenkamp A (2012) Nephrological abnormalities in patients with transaldolase deficiency. Nephrol Dial Transplant 27(8):3224–3227. doi:10.1093/ndt/gfs061

    Article  CAS  PubMed  Google Scholar 

  14. McKone EF, Emerson SS, Edwards KL, Aitken ML (2003) Effect of genotype on phenotype and mortality in cystic fibrosis: a retrospective cohort study. Lancet 361(9370):1671–1676. doi:10.1016/S0140-6736(03)13368-5

    Article  CAS  PubMed  Google Scholar 

  15. Perl A (2007) The pathogenesis of transaldolase deficiency. IUBMB Life 59(6):365–373. doi:10.1080/15216540701387188

    Article  CAS  PubMed  Google Scholar 

  16. Riazuddin S, Castelein CM, Ahmed ZM, Lalwani AK, Mastroianni MA, Naz S, Wilcox ER (2000) Dominant modifier DFNM1 suppresses recessive deafness DFNB26. Nat Genet 26(4):431–434. doi:10.1038/82558

    Article  CAS  PubMed  Google Scholar 

  17. Saudubray JM, Van Den Berghe G, Walter JH (2012) Inborn metabolic diseases: diagnosis and treatment (5th ed.): springer.com

  18. Thorell S, Gergely P, Banki K, Perl A, Schneider G (2000) The three-dimensional structure of human transaldolase. FEBS Lett 475(3):205–208

    Article  CAS  PubMed  Google Scholar 

  19. Tylki-Szymanska A, Stradomska TJ, Wamelink MM, Salomons GS, Taybert J, Pawłowska J, Jakobs C (2009) Transaldolase deficiency in two new patients with a relative mild phenotype. Mol Genet Metab 97(1):15–17. doi:10.1016/j.ymgme.2009.01.016

    Article  CAS  PubMed  Google Scholar 

  20. Tylki-Szymanska A, Wamelink MM, Stradomska TJ, Salomons GS, Taybert J, Dąbrowska-Leonik N, Rurarz M (2014) Clinical and molecular characteristics of two transaldolase-deficient patients. Eur J Pediatr. doi:10.1007/s00431-014-2261-2

    PubMed Central  PubMed  Google Scholar 

  21. Valayonnopoulos V, Verhoeven NM, Mention K, Salomons GA, Sommelet D, Gonzales M, Touati G, de Lyonalay P, Jakobs C, Saudubray JM (2006) Transaldolase deficiency: a new cause of hydrops fetalis and neonatal multi-organ disease. Pediatrics 149(5):713–717

    Article  Google Scholar 

  22. Verhoeven NM, Huck JH, Roos B, Struys EA, Salomons GS, Douwes AC, Jakobs C (2001) Transaldolase deficiency: liver cirrhosis associated with a new inborn error in the pentose phosphate pathway. Am J Hum Genet 68(5):1086–1092. doi:10.1086/320108

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  23. Verhoeven NM, Wallot M, Huck JH, Dirsch O, Ballauf A, Neudorf U, Jakobs C (2005) A newborn with severe liver failure, cardiomyopathy and transaldolase deficiency. J Inherit Metab Dis 28(2):169–179. doi:10.1007/s10545-005-5261-6

    Article  CAS  PubMed  Google Scholar 

  24. Wamelink MM, Smith DE, Jansen EE, Verhoeven NM, Struys EA, Jakobs C (2007) Detection of transaldolase deficiency by quantification of novel seven-carbon chain carbohydrate biomarkers in urine. J Inherit Metab Dis 30(5):735–742. doi:10.1007/s10545-007-0590-2

    Article  CAS  PubMed  Google Scholar 

  25. Wamelink MM, Struys EA, Salomons GS, Fowler D, Jakobs C, Clayton PT (2008) Transaldolase deficiency in a two-year-old boy with cirrhosis. Mol Genet Metab 94(2):255–258. doi:10.1016/j.ymgme.2008.01.011

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

We are thankful to the patients and their family members for their participation in this research study.

Conflict of interest

All authors have declared that they do not have a financial relationship with the organization that sponsored the research.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Fatma Al-Jasmi.

Additional information

Communicated by Beat Steinmann

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Al-Shamsi, A.M., Ben-Salem, S., Hertecant, J. et al. Transaldolase deficiency caused by the homozygous p.R192C mutation of the TALDO1 gene in four Emirati patients with considerable phenotypic variability. Eur J Pediatr 174, 661–668 (2015). https://doi.org/10.1007/s00431-014-2449-5

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00431-014-2449-5

Keywords

Navigation